Capricor Share Price

Capricor Share Price

NASDAQ: CAPR | Small Cap | Healthcare
$8.28
-$0.21 (-2.47%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Capricor Stock Performance

Open
$8.71
Prev. Close
$8.49
Circuit Range
N/A
Day Range
$8.14 - $9.44
Year Range
$2.96 - $40.37
Volume
1,63,829
Average Traded
$8.89

Capricor Share Price Today

As of 19 November 2026, Capricor Therapeutics, Inc.'s share price is $8.28. The stock opened at $8.71, compared to its previous close of $8.49. During today's trading session, Capricor Therapeutics, Inc.'s share price traded between $8.14 and $9.44, with an average price of $8.79. Over the past 52 weeks, the stock has recorded a high of $40.37 and a low of $2.96. In terms of performance, Capricor Therapeutics, Inc.'s share price has declined by 72.35% over the last six months and is up 54.33% on a year-on-year basis.

Capricor Share Price Chart

Line chart of the Capricor price trend over the selected period. The price fell overall, ranging from 8.19 to 9.43, ending at 8.28.
$8.14$9.44
L
Show Current Price
H

Capricor Stock Fundamentals & Key Indicators

Market Cap
$384.84M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.54
Revenue (TTM)
$0.00
Return On Equity (TTM)
-70.32%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-41.40%

Capricor Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$30.17-$33.94-$40.73-$42.66
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.50%-20.01%-4.74%

Capricor Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.55$25.18$22.27$0.00
Net Profit-$29.02-$22.29-$40.47-$105.04
Net Profit Margin-1138.04%-88.52%-181.72%N/A
Income ChangeN/A23.19%-81.56%-159.55%

Capricor Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets33.017.17.887.21
Current Assets322.94163.3950.8642.89
Total Assets355.95170.4858.7350.09
Non Current Liabilities14.323.994.8614.72
Current Liabilities35.8421.0331.2723.59
Total Liabilities50.1625.0236.1338.31
Shareholders' Equity305.79145.4622.611.79

Capricor Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-69.81-40.0-25.64.91
Investing97.48-116.185.11-35.06
Financing248.89152.7725.584.87

Corporate Actions

Split
Ex-date: 05 Jun 2019

About Capricor

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Capricor Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.85
$8.69
+36.31%
Oct 2026
$9.34
$6.38
-32.72%
Sep 2026
$10.81
$9.47
-5.96%
Aug 2026
$3.81
$10.07
+161.69%
Jul 2026
$24.06
$3.85
-83.99%
Jun 2026
$29.50
$24.05
-19.70%
May 2026
$33.13
$29.95
-10.92%
Apr 2026
$30.27
$33.62
+10.65%
Mar 2026
$26.90
$30.39
+8.79%
Feb 2026
$22.16
$27.93
+27.53%
Jan 2026
$29.09
$21.90
-24.12%
Dec 2025
$5.40
$28.86
+437.93%

Capricor Share Price FAQs